Cite
APA Citation
Danese, S., Vermeire, S., Dignass, A., Panés, J., D'Haens, G., Magro, F., Le Bars, M., Nazar, M., Lahaye, M., Ni, L., Bravatà, I., Gaya, D. R., & Peyrin-Biroulet, L. (n.d.). oP40 Analysis of clinical features associated with favourable outcomes from ustekinumab treat-to-target strategy in Crohn's Disease patients in the STARDUST trial. Journal of Crohn's and colitis, 15, S039. http://access.bl.uk/ark:/81055/vdc_100130765385.0x000016